PLX PHARMA INC (PLXP)

US72942A1079 - Common Stock

0.087  -0.03 (-27.8%)

After market: 0.083 0 (-4.6%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
4.54M8.21M30.00K570.00K750.00K
Cost Of Goods
4.34M4.80MN/AN/AN/A
Gross Profit
202.64K3.40MN/AN/AN/A
Operating Expenses
64.63M44.19M13.49M14.77M11.71M
Research and Development
2.52M4.18M4.34M4.74M3.92M
Selling, General, and Administrative Expenses
62.11M40.01M9.15M10.03M7.79M
Operating Income
-64.42M-40.79M-13.46M-14.20M-10.96M
Interest Income/Expense
36.85M-5.33M-1.75M-6.30M11.86M
Non Recurring Items
N/AN/AN/AN/A0.00
Income Before Taxes
-27.58M-46.13M-15.21M-20.50M900.00K
Income Tax
0.000.000.000.000.00
Net Income
-27.58M-48.65M-16.95M-34.25M900.00K
EBITDA
-64.30M-40.67M-13.34M-14.04M-10.76M
 
Per Share Data
EPS Diluted Total Ops
-0.99-2.06-1.74-3.840.10
Non GAAP EPS
-1.02-2.22-1.85-2.500.11
 
Statistics
Gross Profit Margin
4.46%41.46%N/AN/AN/A
Profit Margin
-606.92%-592.71%-56500.00%-6008.77%120.00%
Operating Profit Margin
-1417.83%-496.95%-44866.67%-2491.23%-1461.33%

All data in USD

Charts